Frontiers in Cardiovascular Medicine

JUNE 18, 2024

Electroacupuncture (EA) has shown significant efficacy as an adjuvant therapy for many cardiovascular diseases by improving microcirculation and reducing ischemia-reperfusion injury. Currently, effective treatment is not available for SF-NR. However, its effects on SF-NR in the AMI patients during PCI are not clear.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Laboratory Ischemia 52

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) This session offers more insights from key clinical trials presented at ACC.24 24 and find out what it all means for your patients. Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of Clinical Investigation - Cardiology

JANUARY 2, 2024

Cardiovascular diseases are the most common cause of worldwide morbidity and mortality, highlighting the necessity for advanced therapeutic strategies. Here, we extended this therapeutic concept toward potential clinical translation.

Cardiac Function 40

Cardiac Function Ischemia Exercise Cardiovascular Disease 40

Journal of Cardiovascular Pharmacology

SEPTEMBER 28, 2023

Coronary reactive hyperemia (CRH) is impaired in cardiovascular diseases, and angiotensin-II (Ang-II) exacerbates it. The hearts were exposed to 15-second ischemia, and CRH was assessed in 10 mice each. Coronary reactive hyperemia (CRH) is impaired in cardiovascular diseases, and angiotensin-II (Ang-II) exacerbates it.

Ischemia 40

Ischemia Cardiovascular Disease Article 40

Stroke Journal

JANUARY 30, 2025

Cognitive impairment (CGI) is common in patients with cardiovascular diseases, contributing to morbidity and mortality, especially among people over the age of 64. Cardiogenic dementia has been suggested to characterize patients suffering from cognitive decline after heart disease.

Dementia 40

Dementia Myocardial Infarction Ischemia Cardiovascular Disease 40

Dr. Smith's ECG Blog

NOVEMBER 15, 2023

This suggests further severe ischemia. See "Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk".) Detailed coronary artery evaluation not performed. Exam was interpreted and discussed with Dr. Simegn of cardiology, who reviewed the cardiac portion.

Coronary Angiogram 109

Coronary Angiogram Plaque Thrombosis STEMI 109

Frontiers in Cardiovascular Medicine

MARCH 18, 2025

The immune response plays a vital role in the development of cardiovascular diseases (CVDs). As a crucial component of the innate immune system, neutrophils are involved in the initial inflammatory response following cardiovascular injury, thereby inducing subsequent damage and promoting recovery.

Cardiovascular Disease 52

Cardiovascular Disease Atrial Fibrillation Atherosclerosis Heart Failure 52

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

Cardiovascular diseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Dr. Smith's ECG Blog

NOVEMBER 30, 2022

See "Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk".) From Gue at al. STEMI MINOCA versus NSTEMI MINOCA STEMI occurs in the presence of transmural ischaemia due to transient or persistent complete occlusion of the infarct-related coronary artery.

Plaque 52

Plaque Chest Pain Thrombosis Stenosis 52

DAIC

JULY 18, 2024

The lead investigators for the study are Dr. Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link].

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

DAIC

MAY 14, 2024

Within the complex umbrella of cardiovascular disease, CAD is a type of heart disease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

DECEMBER 27, 2023

“I am very honored to receive the Schottenstein Prize and am truly humbled to be listed alongside the previous distinguished recipients of the award,” said Kitsis, who is the Dr. Gerald and Myra Dorros Chair in Cardiovascular Disease at Albert Einstein and serves as director of the Einstein Wilf Family Cardiovascular Research Institute.“Dr.

Heart Attack 111

Heart Attack Heart attacks Research Myocardial Infarction 111

DAIC

MAY 16, 2024

PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. If left untreated, PAD may progress to severe forms known as chronic limb-threatening ischemia (CLTI) and acute limb ischemia (ALI).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Heart 2023 Conference

APRIL 20, 2022

Avocado consumption of at least two servings per week is linked to a lower risk of cardiovascular disease. Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

Cardiometabolic Health Congress

MAY 10, 2024

The American Heart Association’s scientific statement, “Psychological Health, Well-Being, and the Mind-Heart-Body Connection,” emphasizes the need to evaluate and address psychological health in patients with or at risk for cardiovascular disease (CVD).

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59

DAIC

MARCH 25, 2024

Session 510) To Treat or Not to Treat Anatomy and Ischemia? BE ACTIVE—about physical activity and how physical activity is enhanced in patients looking at financial incentivization as well as gamification, and what that does for physical activity with regards to patients who have MI and a high risk for cardiovascular disease.

Education 59

Education Cardiogenic Shock Heart Failure Plaque 59

Wellnest

DECEMBER 11, 2023

As beneficial as ART Therapy is, recent studies suggest that INSTIs and CCR5 antagonists exhibit cardiovascular toxicity, raising valid concerns as it can lead to a higher risk of CVDs. ST-Segment Changes: Changes in the ST segment of an EKG can be indicative of myocardial ischemia or infarction.

Quality of Life 52

Quality of Life Myocardial Infarction Public Health Arrhythmia 52

Dr. Smith's ECG Blog

OCTOBER 2, 2021

He had no apparent risk factors for cardiovascular disease. This proves that the first one was, surprisingly, due to ischemia!! At the time of arrival to the ED, the patient reported 1/10 chest pain with normal vital signs. A prior ECG was available for comparison.

Chest Pain 52

Chest Pain Ultrasound STEMI Myocardial Infarction 52

Dr. Smith's ECG Blog

APRIL 8, 2015

Evidence of acute ischemia (may be subtle) vii. History of Cardiovascular disease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. ST segment and T wave abnormalities consistent with or possibly related to myocardial ischemia. Left BBB vi. LVH or RV d.

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52

Cardiometabolic Health Congress

JANUARY 2, 2025

September 2024 Approvals Flurpiridaz F 18 Approval Date: September 27, 2024 Indication: A radioactive positron emission tomography (PET) tracer for imaging myocardial ischemia and infarction in adults with suspected or known coronary artery disease.

Coronary Artery Disease 52

Coronary Artery Disease Stents Stent Innovation 52

Frontiers in Cardiovascular Medicine

JANUARY 14, 2025

Myocardial fibrosis (MF) is a common pathological manifestation of many cardiovascular diseases, such as myocardial infarction, myocardial ischemia, and sudden cardiac death.

Sudden Cardiac Death 52

Sudden Cardiac Death Myocardial Infarction Ischemia Cardiovascular Disease 52